August 10, 2022
Loading...
You are here:  Home  >  'Atara Biotherapeutics'
Latest

Atara announces plan to cut workforce by 20%

By   /  Tuesday, August 9th, 2022  /  Banking & Finance, Earnings, Health Care & Life Science, Latest news, Regions, Subscriber content, Top Stories, Top Story, Tri-County Public Companies, Ventura County  /  Comments Off on Atara announces plan to cut workforce by 20%

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Atara reports Q1 loss as it pursues EU and FDA approvals

By   /  Wednesday, May 11th, 2022  /  Banking & Finance, Earnings, Health Care & Life Science, Latest news, Regions, Subscriber content, Top Stories, Tri-County Public Companies, Ventura County  /  Comments Off on Atara reports Q1 loss as it pursues EU and FDA approvals

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Sale of Atara’s Thousand Oaks property will fund company’s drug development through 2023

By   /  Thursday, April 14th, 2022  /  Health Care & Life Science, Latest news, Regions, Subscriber content, Top Stories, Ventura County  /  Comments Off on Sale of Atara’s Thousand Oaks property will fund company’s drug development through 2023

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

In Thousand Oaks, biotech execs discuss industry’s ‘rising tide,’ lament area’s lack of housing

By   /  Friday, April 8th, 2022  /  Health Care & Life Science, Latest news, Regions, Top Stories, Top Story, Ventura County  /  Comments Off on In Thousand Oaks, biotech execs discuss industry’s ‘rising tide,’ lament area’s lack of housing

In a dark period for the Ventura County economy, immediately before and during the COVID-19 pandemic, the biotechnology sector in the Conejo Valley has been a bright spot. The sector has grown in jobs, economic output and new businesses since 2019, even when the county as a whole has not, according to data presented on Read More →

Latest

Atara closes $100M sale of Thousand Oaks facility

By   /  Wednesday, April 6th, 2022  /  Banking & Finance, Health Care & Life Science, Latest news, Regions, Tri-County Public Companies, Ventura County  /  Comments Off on Atara closes $100M sale of Thousand Oaks facility

Atara Biotherapeutics, a drugmaker based in South San Francisco with a large presence in Thousand Oaks, announced April 4 that its cell therapy manufacturing facility in Thousand Oaks was purchased by Fujifilm Corp. for $100 million. The deal was first announced in January and is part of a long-term strategic supply agreement between Atara and Read More →

Latest

Atara reports patient death in cancer treatment study

By   /  Tuesday, February 22nd, 2022  /  Banking & Finance, Health Care & Life Science, Latest news, Tri-County Public Companies  /  Comments Off on Atara reports patient death in cancer treatment study

Atara Biotherapeutics, a South San Francisco-based drug development company with major operations in Thousand Oaks, reported to the U.S. Food and Drug Administration on Feb. 18 that a patient died in one of its Phase 1 trials. The patient, who was being treated at a Memorial Sloan Kettering Cancer Center location in New York, suffered Read More →

Latest

Atara reports growing losses, but plenty of cash left

By   /  Friday, November 5th, 2021  /  Banking & Finance, Earnings, East Ventura County, Health Care & Life Science, Latest news, Technology, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Atara reports growing losses, but plenty of cash left

Atara Biotherapeutics continued seeing losses in the third quarter of fiscal year 2021, but has enough cash on hand to remain solvent as it awaits news on its tab-cel therapy treatment in early 2022. Atara, a South San Francisco-based immunotherapy based company with major operations in Westlake Village, reported net losses of $84.7 million in Read More →